Medirom Healthcare Technologies Inc. Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount
Medirom Healthcare Technologies Inc. (MRM) reported Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount of JPY 10.54 million for the 12-month period ending 2020-12-31, per its 20-F filed 2023-05-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount · last filed 2023-05-30
| Period end | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 12 month |
|---|---|
| 2020-12-31 | 10.54M JPY 20-F · filed 2023-05-30 |
| 2019-12-31 | 0.00 JPY 20-F · filed 2022-11-14 |